Dakota Wealth Management Makes New $1.19 Million Investment in Tempus AI, Inc. (NASDAQ:TEM)

Dakota Wealth Management bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 20,944 shares of the company's stock, valued at approximately $1,185,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Sandia Investment Management LP acquired a new stake in shares of Tempus AI in the second quarter valued at about $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in Tempus AI during the third quarter worth approximately $258,000. Clarus Group Inc. acquired a new position in Tempus AI during the third quarter worth approximately $283,000. Renaissance Capital LLC acquired a new position in Tempus AI during the third quarter worth approximately $633,000. Finally, Northwestern University acquired a new position in Tempus AI during the second quarter worth approximately $491,000.

Tempus AI Trading Down 5.8 %

Shares of TEM stock traded down $2.70 during trading on Friday, hitting $43.51. The company had a trading volume of 832,400 shares, compared to its average volume of 1,130,295. The company has a current ratio of 3.70, a quick ratio of 3.52 and a debt-to-equity ratio of 4.50. The stock's 50-day simple moving average is $52.55. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $77.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, research analysts predict that Tempus AI, Inc. will post -6.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on TEM shares. Loop Capital boosted their price target on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a research report on Tuesday, October 15th. Needham & Company LLC reissued a "buy" rating and set a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. JPMorgan Chase & Co. upped their target price on Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Piper Sandler began coverage on Tempus AI in a research report on Monday, August 12th. They issued a "neutral" rating and a $40.00 target price on the stock. Finally, TD Cowen began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a "buy" rating and a $50.00 target price on the stock. Two analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $48.67.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.